AU7132998A - Substituted pyrrolopyridines useful in the treatment of inflammatory diseases - Google Patents

Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Info

Publication number
AU7132998A
AU7132998A AU71329/98A AU7132998A AU7132998A AU 7132998 A AU7132998 A AU 7132998A AU 71329/98 A AU71329/98 A AU 71329/98A AU 7132998 A AU7132998 A AU 7132998A AU 7132998 A AU7132998 A AU 7132998A
Authority
AU
Australia
Prior art keywords
treatment
inflammatory diseases
useful
substituted pyrrolopyridines
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71329/98A
Other languages
English (en)
Inventor
John H. Dodd
James R. Henry
Kenneth Rupert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORTHO-MCNEIL Corp Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU7132998A publication Critical patent/AU7132998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU71329/98A 1997-04-24 1998-04-17 Substituted pyrrolopyridines useful in the treatment of inflammatory diseases Abandoned AU7132998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4424497P 1997-04-24 1997-04-24
US60044244 1997-04-24
PCT/US1998/007831 WO1998047899A1 (en) 1997-04-24 1998-04-17 Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
AU7132998A true AU7132998A (en) 1998-11-13

Family

ID=21931293

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71329/98A Abandoned AU7132998A (en) 1997-04-24 1998-04-17 Substituted pyrrolopyridines useful in the treatment of inflammatory diseases

Country Status (4)

Country Link
AR (1) AR012593A1 (es)
AU (1) AU7132998A (es)
WO (1) WO1998047899A1 (es)
ZA (1) ZA983452B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166048A (en) * 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
ATE264318T1 (de) 1996-11-19 2004-04-15 Amgen Inc Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
CN1279682A (zh) 1997-10-20 2001-01-10 霍夫曼-拉罗奇有限公司 双环激酶抑制剂
AU1053399A (en) * 1997-11-14 1999-06-07 Sankyo Company Limited Pyridylpyrrole derivatives
AU4694999A (en) * 1998-08-06 2000-02-28 Warner-Lambert Company Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
EP1119254A4 (en) * 1998-10-07 2004-05-12 Smithkline Beecham Corp STROKE TREATMENT
DE69914357T2 (de) 1998-11-04 2004-11-11 Smithkline Beecham Corp. Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ES2254238T3 (es) * 1999-10-27 2006-06-16 Novartis Ag Compuestos de tiazol e imidazo(4,5-b)piridina y su uso farmaceutico.
GB9930698D0 (en) * 1999-12-24 2000-02-16 Rhone Poulenc Rorer Ltd Chemical compounds
OA12514A (en) * 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
WO2001057018A1 (en) * 2000-02-02 2001-08-09 Abbott Laboratories Azaazulene inhibitors of p38 map kinase and tnf-alpha
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
CA2480317A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
SG135051A1 (en) * 2002-06-20 2007-09-28 Aventis Pharma Ltd Azaindoles
DE60310730T2 (de) 2002-07-09 2007-05-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
EP1599475A2 (en) * 2003-03-06 2005-11-30 Eisai Co., Ltd. Jnk inhibitors
GB0305142D0 (en) 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
EP1628975A2 (en) 2003-05-16 2006-03-01 Eisai Co., Ltd. Jnk inhibitors
WO2005051302A2 (en) * 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
EP1696920B8 (en) 2003-12-19 2015-05-06 Plexxikon Inc. Compounds and methods for development of ret modulators
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EP1676574A3 (en) 2004-12-30 2006-07-26 Johnson & Johnson Vision Care, Inc. Methods for promoting survival of transplanted tissues and cells
DE602006014540D1 (en) * 2005-05-16 2010-07-08 Irm Llc Pyrrolopyridinderivate als proteinkinaseinhibitoren
GB0516156D0 (en) 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
JP5324785B2 (ja) 2005-10-28 2013-10-23 武田薬品工業株式会社 複素環アミド化合物及びその用途
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
CN102112478A (zh) * 2008-06-10 2011-06-29 普莱希科公司 用于激酶调节的5h-吡咯[2，3-b]吡嗪衍生物和其适应症
CN105237530A (zh) 2009-04-03 2016-01-13 豪夫迈罗氏公司 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途
WO2011057022A1 (en) 2009-11-06 2011-05-12 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PT2672967T (pt) 2011-02-07 2018-12-07 Plexxikon Inc Compostos e métodos de modulação da quinase e suas indicações
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
WO2013092467A1 (en) * 2011-12-20 2013-06-27 F. Hoffmann-La Roche Ag 7-azaindole inhibitors of crac
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
FR3001219A1 (fr) * 2013-01-22 2014-07-25 Centre Nat Rech Scient Inhibiteurs de kinases
ES2821971T3 (es) * 2015-10-13 2021-04-28 Inst Nat Sante Rech Med Derivados de la sibirilina sustituidos en N1 y N7 y su utilización como inhibidores de la necroptosis celular

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228050A1 (en) * 1995-08-10 1997-02-20 Harold G. Selnick 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use

Also Published As

Publication number Publication date
AR012593A1 (es) 2000-11-08
ZA983452B (en) 1999-10-25
WO1998047899A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
IL133766A0 (en) 2-substituted imidazoles useful in the treatment of inflammatory diseases
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
HUP0102142A3 (en) Use of cyclosporins in the treatment of inflammatory autoimmune diseases
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2418499A (en) Org-5222 in the treatment of depression
AU2001260834A1 (en) The treatment of herpes
AU5056099A (en) Compounds for use in the treatment of inflammation
HK1025954A1 (en) Triptolide derivatives useful in the treatment of autoimmune diseases
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU8760298A (en) Coup-tfi directed therapies in the treatment of disease
AU9082798A (en) Treatment of inflammatory conditions
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
AU2002300624A1 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
AU6408598A (en) Unsatured fatty acid anhydrides for use in the therapy
AU1801297A (en) Spiro-ketal derivatives and their use as therapeutic agents
AU2002306210A1 (en) 2-substituted imidazoles useful in the treatment of inflammatory diseases
AU7639998A (en) Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treatment ofestrogen related diseases or syndromes
SI0983275T1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase